 |
|
Treatment of Central Diabetes Insipidus in Adults and Children With DesmopressinA Synthetic Analogue of Vasopressin
Fuad Ziai, MD;
Roderich Walter, PhD;
Ira M. Rosenthal, MD
Arch Intern Med. 1978;138(9):1382-1385.
Abstract
Modification of the natural vasopressin molecule to form desmopressin acetate (DDAVP) resulted in a compound with prolonged antidiuretic activity and virtual elimination of vasopressor activity. Twenty-one patients with central diabetes insipidus who ranged in age from 3 to 68 years were treated with DDAVP, which was administered intranasally in a dosage ranging from 10 µg every 12 hours to 20 µg every eight hours. Effective control of symptoms was obtained in all cases. There were no consequential toxic effects. As previously reported, DDAVP appears to be the preferred drug for the management of central diabetes insipidus. Biochemical alteration of hormones may enhance desired therapeutic activity and eliminate toxic effects. The development of DDAVP is an example of the potential for development of useful therapeutic peptides.
(Arch Intern Med 138:1382-1385, 1978)
Author Affiliations
From the Department of Pediatrics, Abraham Lincoln School of Medicine, (Drs Ziai and Rosenthal) and the Department of Physiology and Biophysics, School of Basic Medical Sciences (Dr Walter), University of Illinois Medical Center, Chicago.
Footnotes
Accepted for publication Nov 30, 1977.
Reprint requests to Department of Pediatrics, University of Illinois Hospital, 840 S Wood St, Chicago, IL 60612 (Dr Rosenthal).
 CiteULike  Connotea  Delicious  Digg  Facebook  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Sublingual Administration of Desmopressin: Effectiveness in an Infant With Holoprosencephaly and Central Diabetes Insipidus
Kappy and Sonderer
Arch Pediatr Adolesc Med 1987;141:84-85.
ABSTRACT
Drugs Five Years Later: Desmopressin
RICHARDSON and ROBINSON
ANN INTERN MED 1985;103:228-239.
ABSTRACT
|
